• Skills People And Talent

Stablepharma is delighted to announce another new recruit to the Science Team in Spain

Stablepharma announce another new recruit to the Science team in Madrid, Spain based at Stablepharma’s R&D Center of Excellence (CoE) in Qube Technology Park

Virology Research Services Chooses Discovery Park as it relocates London team

A team of virologists move to Discovery Park to expand operations. Demand for lab and manufacturing space continues at Discovery Park to support the UK’s booming life science industry.

The Oxford Science Park appoints Jitesh Patel as Development Manager

New role enables accelerated delivery of buildings for existing & new occupiers

CEO Update | 17 January 2022

The UK sector was out in virtual force at the annual JP Morgan Healthcare conference held virtually last week. It was great to see UK companies at the forefront of the global themes. I’m really looking forward to seeing many of you on 27 January as we gather in person to celebrate the achievements of the sector at the BIA Gala Dinner. I’m glad to confirm that Science Minister George Freeman MP will be our pre dinner keynote speaker.

Cell and Gene Therapy Catapult appoints Ian McCubbin OBE, CBE, as Chair of the Board

London, 17th January 2022 – The Cell and Gene Therapy Catapult (CGT Catapult), an independent technology and innovation organisation, announces today the appointment of Ian McCubbin OBE, CBE, to its Board of Non-Executive Directors as Chairman, effective 1st February 2022. With over 30 years of experience in the pharmaceutical industry and as a pharmacist by training, Ian has worked for industry leading companies including GlaxoSmithKline (GSK).

Strong demand fuels rapid growth at Discovery Park

Kent life sciences hub sees upsurge in tenants.

Charles River Integrates Cell and Gene Therapy Acquisitions to Enhance End-to-End Offering for Developers

In March 2021, Cobra and Cognate officially joined the Charles River family and in January 2022, launched the rebranding of our businesses into Charles River.

Medical devices regulatory specialist joins Boyds

Leading pharmaceutical and biotech product development consultancy, Boyds, has hired regulatory expert in the pharma, biotech and medical devices sectors, Eamonn McGowran as Associate Director.

Biotech Industry Skills & Talent update: Reflections on the last quarter of 2021

Read an update from Dr Kate Barclay MBA CEng FIChemE on the BIA 2021 Skills and Talent workplan and find out how we are influencing a skills-led recovery to address significant skills shortages across the UK life sciences sector.

Coulter Partners places Chief Medical Officer in the US for Apollo Therapeutics

Coulter Partners partnered recently with Apollo Therapeutics, a portfolio-based biopharmaceutical company rapidly advancing transformative treatments based on breakthrough discoveries, and was pleased to secure the appointment of Dr. Sanjay Aggarwal as the company’s Chief Medical Officer.